Home LiteratureArticle Details
PMID: 16809770 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

5'-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments.

Molecular and cellular biology ·Vol. 26 ·No. 14 ·2006-07-00 ·Pages 5336-47

Laderoute KR, Amin K, Calaoagan JM, Knapp M, Le T, Orduna J, Foretz M, Viollet B

Abstract

Low oxygen gradients (hypoxia and anoxia) are important determinants of pathological conditions under which the tissue blood supply is deficient or defective, such as in solid tumors. We have been investigating the relationship between the activation of hypoxia-inducible factor 1 (HIF-1), the primary transcriptional regulator of the mammalian response to hypoxia, and 5'-AMP-activated protein kinase (AMPK), another regulatory system important for controlling cellular energy metabolism. In the present study, we used mouse embryo fibroblasts nullizygous for HIF-1alpha or AMPK expression to show that AMPK is rapidly activated in vitro by both physiological and pathophysiological low-oxygen conditions, independently of HIF-1 activity. These findings imply that HIF-1 and AMPK are components of a concerted cellular response to maintain energy homeostasis in low-oxygen or ischemic-tissue microenvironments. Finally, we used transformed derivatives of wild-type and HIF-1alpha- or AMPKalpha-null mouse embryo fibroblasts to determine whether AMPK is activated in vivo. We obtained evidence that AMPK is activated in authentic hypoxic tumor microenvironments and that this activity overlaps with regions of hypoxia detected by a chemical probe. We also showed that AMPK is important for the growth of this tumor model.

MeSH Terms
AMP-Activated Protein Kinases Acetyl-CoA Carboxylase/metabolism Adenosine Triphosphate/metabolism Animals Cells, Cultured Enzyme Activation Female Genes, ras Glucose/metabolism Hypoxia/enzymology Hypoxia-Inducible Factor 1, alpha Subunit/deficiency,genetics,metabolism Mice Mice, Inbred BALB C Mice, Knockout Mice, Nude Multienzyme Complexes/deficiency,genetics,metabolism Neoplasms, Experimental/enzymology,genetics,metabolism Phosphorylation Protein Serine-Threonine Kinases/deficiency,genetics,metabolism Transformation, Genetic
Chemicals
Hif1a protein, mouse Hypoxia-Inducible Factor 1, alpha Subunit Multienzyme Complexes Adenosine Triphosphate Protein Serine-Threonine Kinases AMP-Activated Protein Kinases Acetyl-CoA Carboxylase Glucose
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Laderoute Keith R
SRI International, Bldg. L, Rm. A258, 333 Ravenswood Ave., Menlo Park, CA 94025, USA. keith.laderoute@sri.com
Amin Khalid
Calaoagan Joy M
Knapp Merrill
Le Theresamai
Orduna Juan
Foretz Marc
Viollet Benoit
References (61)
61 references, click to expand
  1. A clinical study of hypoxia and metallothionein protein expression in squamous cell carcinomas.
    Clin Cancer Res. 2000 Mar;6(3):855-62 PMID: 10741707
  2. AMP-dependent protein kinase alpha 2 isoform promotes hypoxia-induced VEGF expression in human glioblastoma.
    Glia. 2006 May;53(7):733-43 PMID: 16518831
  3. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia.
    Curr Biol. 2000 Oct 19;10(20):1247-55 PMID: 11069105
  4. The novel tubulin-binding drug BTO-956 inhibits R3230AC mammary carcinoma growth and angiogenesis in Fischer 344 rats.
    Clin Cancer Res. 2001 Aug;7(8):2590-6 PMID: 11489843
  5. Insulin antagonizes AMP-activated protein kinase activation by ischemia or anoxia in rat hearts, without affecting total adenine nucleotides.
    FEBS Lett. 2001 Sep 21;505(3):348-52 PMID: 11576526
  6. The response of c-jun/AP-1 to chronic hypoxia is hypoxia-inducible factor 1 alpha dependent.
    Mol Cell Biol. 2002 Apr;22(8):2515-23 PMID: 11909946
  7. The stimulation of glycolysis by hypoxia in activated monocytes is mediated by AMP-activated protein kinase and inducible 6-phosphofructo-2-kinase.
    J Biol Chem. 2002 Aug 23;277(34):30778-83 PMID: 12065600
  8. Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation.
    Oncogene. 2002 Sep 5;21(39):6082-90 PMID: 12203120
  9. Hypoxia and nitric oxide treatment confer tolerance to glucose starvation in a 5'-AMP-activated protein kinase-dependent manner.
    J Biol Chem. 2002 Sep 6;277(36):32791-8 PMID: 12091379
  10. Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase.
    Biochem Soc Trans. 2002 Nov;30(Pt 6):1064-70 PMID: 12440973
  11. HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors.
    Int J Radiat Oncol Biol Phys. 2002 Dec 1;54(5):1537-49 PMID: 12459383
  12. Identification of a novel protein kinase mediating Akt survival signaling to the ATM protein.
    J Biol Chem. 2003 Jan 3;278(1):48-53 PMID: 12409306
  13. The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity.
    J Clin Invest. 2003 Jan;111(1):91-8 PMID: 12511592
  14. GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding.
    Int J Cancer. 2003 Mar 10;104(1):85-91 PMID: 12532423
  15. New targets of AMP-activated protein kinase.
    Biochem Soc Trans. 2003 Feb;31(Pt 1):213-5 PMID: 12546687
  16. AMP-activated protein kinase regulates gene expression by direct phosphorylation of nuclear proteins.
    Biochem Soc Trans. 2003 Feb;31(Pt 1):224-7 PMID: 12546690
  17. Hypoxia-inducible factor and its biomedical relevance.
    J Biol Chem. 2003 May 30;278(22):19575-8 PMID: 12639949
  18. Management of cellular energy by the AMP-activated protein kinase system.
    FEBS Lett. 2003 Jul 3;546(1):113-20 PMID: 12829246
  19. AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress.
    J Biol Chem. 2003 Aug 15;278(33):31000-6 PMID: 12788940
  20. Targeting HIF-1 for cancer therapy.
    Nat Rev Cancer. 2003 Oct;3(10):721-32 PMID: 13130303
  21. Roles of 5'-AMP-activated protein kinase (AMPK) in mammalian glucose homoeostasis.
    Biochem J. 2003 Oct 1;375(Pt 1):1-16 PMID: 12839490
  22. AMP-activated protein kinase activity is critical for hypoxia-inducible factor-1 transcriptional activity and its target gene expression under hypoxic conditions in DU145 cells.
    J Biol Chem. 2003 Oct 10;278(41):39653-61 PMID: 12900407
  23. Myocardial ischemia and increased heart work modulate the phosphorylation state of eukaryotic elongation factor-2.
    J Biol Chem. 2003 Oct 24;278(43):41970-6 PMID: 12920134
  24. Induction of cell-cell detachment during glucose starvation through F-actin conversion by SNARK, the fourth member of the AMP-activated protein kinase catalytic subunit family.
    Biochem Biophys Res Commun. 2003 Nov 7;311(1):156-61 PMID: 14575707
  25. Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle.
    J Biol Chem. 2004 Jan 9;279(2):1070-9 PMID: 14573616
  26. Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2-kinase pathway.
    Nat Cell Biol. 2004 Jan;6(1):45-51 PMID: 14688792
  27. The AMP-activated protein kinase cascade--a unifying system for energy control.
    Trends Biochem Sci. 2004 Jan;29(1):18-24 PMID: 14729328
  28. Network biology: understanding the cell's functional organization.
    Nat Rev Genet. 2004 Feb;5(2):101-13 PMID: 14735121
  29. Evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinomas.
    Br J Cancer. 2004 Feb 9;90(3):728-35 PMID: 14760391
  30. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1.
    EMBO J. 2004 Feb 25;23(4):833-43 PMID: 14976552
  31. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress.
    Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3329-35 PMID: 14985505
  32. ARK5 is a tumor invasion-associated factor downstream of Akt signaling.
    Mol Cell Biol. 2004 Apr;24(8):3526-35 PMID: 15060171
  33. HIF-1 and hypoxic response: the plot thickens.
    Curr Opin Genet Dev. 2004 Feb;14(1):81-5 PMID: 15108809
  34. Glucose utilization is essential for hypoxia-inducible factor 1 alpha-dependent phosphorylation of c-Jun.
    Mol Cell Biol. 2004 May;24(10):4128-37 PMID: 15121835
  35. Tumor microenvironmental physiology and its implications for radiation oncology.
    Semin Radiat Oncol. 2004 Jul;14(3):198-206 PMID: 15254862
  36. The hypoxic tumor microenvironment and gene expression.
    Semin Radiat Oncol. 2004 Jul;14(3):207-14 PMID: 15254863
  37. Dysregulation of HIF and VEGF is a unifying feature of the familial hamartoma syndromes.
    Cancer Cell. 2004 Jul;6(1):7-10 PMID: 15261137
  38. Tumor-dependent kinetics of partial pressure of oxygen fluctuations during air and oxygen breathing.
    Cancer Res. 2004 Sep 1;64(17):6010-7 PMID: 15342381
  39. Strong association of ARK5 with tumor invasion and metastasis.
    J Exp Clin Cancer Res. 2004 Jun;23(2):263-8 PMID: 15354411
  40. Regulation of caspase-6 and FLIP by the AMPK family member ARK5.
    Oncogene. 2004 Sep 16;23(42):7067-75 PMID: 15273717
  41. Characteristics of an SV40-plasmid recombinant and its movement into and out of the genome of a murine cell.
    Cell. 1980 Aug;21(1):127-39 PMID: 6250708
  42. Cellular transformation and malignancy induced by ras require c-jun.
    Mol Cell Biol. 1996 Aug;16(8):4504-11 PMID: 8754851
  43. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension.
    Am J Physiol. 1996 Oct;271(4 Pt 1):C1172-80 PMID: 8897823
  44. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker.
    Cancer Res. 1998 Sep 1;58(17):3765-8 PMID: 9731480
  45. Tumor-derived expression of vascular endothelial growth factor is a critical factor in tumor expansion and vascular function.
    Cancer Res. 1999 Apr 1;59(7):1592-8 PMID: 10197634
  46. LKB1, the multitasking tumour suppressor kinase.
    J Clin Pathol. 2005 Jan;58(1):15-9 PMID: 15623475
  47. Erythropoietin and erythropoietin receptor expression in head and neck cancer: relationship to tumor hypoxia.
    Clin Cancer Res. 2005 Jan 1;11(1):20-7 PMID: 15671524
  48. Glucose deprivation increases mRNA stability of vascular endothelial growth factor through activation of AMP-activated protein kinase in DU145 prostate carcinoma.
    J Biol Chem. 2005 Mar 18;280(11):9963-72 PMID: 15640157
  49. Hypoxia and AMP independently regulate AMP-activated protein kinase activity in heart.
    Am J Physiol Heart Circ Physiol. 2005 May;288(5):H2412-21 PMID: 15637122
  50. Spatial heterogeneity and oxygen dependence of glucose consumption in R3230Ac and fibrosarcomas of the Fischer 344 rat.
    Cancer Res. 2005 Jun 15;65(12):5163-71 PMID: 15958560
  51. Hypoxia inhibits adipocyte differentiation in a HDAC-independent manner.
    Biochem Biophys Res Commun. 2005 Aug 12;333(4):1178-84 PMID: 15975549
  52. Activating AMP-activated protein kinase without AMP.
    Mol Cell. 2005 Aug 5;19(3):289-90 PMID: 16061173
  53. The interaction between HIF-1 and AP-1 transcription factors in response to low oxygen.
    Semin Cell Dev Biol. 2005 Aug-Oct;16(4-5):502-13 PMID: 16144688
  54. Involvement of transforming growth factor-beta 1 signaling in hypoxia-induced tolerance to glucose starvation.
    J Biol Chem. 2005 Sep 9;280(36):31557-63 PMID: 16014625
  55. AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress.
    Mol Cell Biol. 2005 Nov;25(21):9554-75 PMID: 16227605
  56. The metal-responsive transcription factor-1 contributes to HIF-1 activation during hypoxic stress.
    Biochem Biophys Res Commun. 2005 Nov 25;337(3):860-7 PMID: 16216223
  57. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase.
    J Biol Chem. 2005 Nov 25;280(47):39582-93 PMID: 16176927
  58. Does AMP-activated protein kinase couple inhibition of mitochondrial oxidative phosphorylation by hypoxia to calcium signaling in O2-sensing cells?
    J Biol Chem. 2005 Dec 16;280(50):41504-11 PMID: 16199527
  59. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways.
    Cancer Res. 2006 Jan 1;66(1):315-23 PMID: 16397245
  60. Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways.
    Mol Cancer Ther. 2006 Feb;5(2):430-7 PMID: 16505118
  61. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth.
    Cancer Res. 2000 Aug 1;60(15):4010-5 PMID: 10945599
Article Info
Journal
Molecular and cellular biology
Abbr.
Mol Cell Biol
ISSN
0270-7306
Published
2006-07-00
Pages
5336-47
Language
English
Region
United States
NLM ID
8109087
PMCID
PMC1592699
Subset
IM
Grants
NCI NIH HHS · R01 CA073807 · United States
NCI NIH HHS · CA73807 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com